Contact
Please use this form to send email to PR contact of this press release:
SELLAS Receives EMA Orphan Drug Designation for SLS009 for Treatment of Peripheral T-cell Lymphomas
TO:
Please use this form to send email to PR contact of this press release:
SELLAS Receives EMA Orphan Drug Designation for SLS009 for Treatment of Peripheral T-cell Lymphomas
TO: